You can watch VKTXW and buy or sell other stocks, options, and ETFs commission-free!
Viking Therapeutics, Inc. Warrants, also called Viking Therapeutics (Warrant), is a clinical-stage biopharmaceutical company, which engages in the development of novel therapies for patients suffering from metabolic and endocrine disorders. The firm's clinical program VK5211, treats patients recovering from non-elective hip fracture surgery. It also specializes in development of VK2809 and VK0214. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA. The listed name for VKTXW is Viking Therapeutics, Inc. Warrants.
Brian Lian, PhD, MBA
San Diego, California
52 Week High
52 Week Low